Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: Predictive factors of response and outcome

American Journal of Gastroenterology

Volumn 97, Issue 2, 2002, Pages 292-297

  Levy, Michaël ^a   Copie Bergman, Christiane ^a   Traulle, Catherine ^b   Lavergne Slove, Anne ^c   Brousse, Nicole ^d   Flejou, Jean François ^e   De Mascarel, Antoine ^f   Hemery, François ^a   Gaulard, Philippe ^a   Delchier, Jean Charles ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPIC ECHOGRAPHY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; STOMACH LYMPHOMA; TREATMENT OUTCOME;

ADULT; AGED; AMOXICILLIN; ANTINEOPLASTIC AGENTS, ALKYLATING; BIOPSY, NEEDLE; CHLORAMBUCIL; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 0036181867     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)04022-9     Document Type: Article

References (26)

1. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma
2. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
3. Helicobacter pylori infection and gastric lymphoma
4. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
5. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue
6. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
7. Helicobacter priori eradication for the treatment of low-grade gastric MALT lymphoma: Follow-up together with sequential molecular studies
8. Eradication of Helicobacter priori, and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: Results of an ongoing multicenter trial
9. Low grade B cell mucosa associated lymphoid tissue lymphoma of the stomach: Clinical and endoscopic features, treatment, and outcome
10. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression
11. Histological grading in gastric lymphoma: Pretreatment criteria and clinical relevance
12. Cure of Helicobacter priori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma
13. Klinische stadieneinteilung der nicht-hodgkin lymphome
14. Endoscopic ultra-sonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically
15. Histological grading with clinical relevance in gastric mucosa-associated lymphoid tissue (MALT) lymphoma
16. World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting. Airlie House, Virginia, November 1997
17. Regression of high-grade gastric mucosa-associated lymphoid tissue lymphoma with Helicobacter pylori after triple antibiotic therapy
18. Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma
19. Endoscopic ultrasonography in the local staging of primary gastric lymphoma
20. Endoscopic ultrasonography in primary gastric lymphoma: Correlation with endoscopic and histologic findings
21. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging
22. Endosonographic features predictive of lymph node metastasis
23. Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: True relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy
24. Is there an obligatory need for an oncological treatment modality if Helicobater pylori eradication is not followed by complete regression of gastric low-grade lymphoma of MALT type?
25. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone
26. Therapy of B-cell lymphomas with monoclonal antibodies and radioimmunoconjugates: The Seattle experience